contents table Logo Lexparency.org lexp
On subjecting 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) to control measures
Final

Final

Done at Luxembourg, 8 October 2015.

For the Council

The President

J. ASSELBORN